Year: 2026
Type: article
Abstract: The 24th International Pathogenic Neisseria Conference (IPNC) marked a shift toward a balanced forum addressing both meningococcal and gonococcal disease. This drove discussion on how multivalent meningococcal vaccines are enabling the WHO roadmap to defeat meningitis by 2030, while highlighting growing evidence that effective gonococcal vaccines are achievable. Major challenges remain, including antimicrobial resistance, limited genomic surveillance and incomplete understanding of pathogenesis and immune evasion. These reflections shaped this perspective piece.
Source: npj Vaccines
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,890
OpenAlex ID: W7135245192
